LSTA (Lisata Therapeutics) Short Interest


LSTA Lisata Therapeutics Inc LSTA
19 GF Score
Price $3.45
! 4 Warning Signs
View Full Analysis

What is Lisata Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSTA vs NRSN, SNTI, DYAI: Short Interest Comparison

For the Biotechnology subindustry, Lisata Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lisata Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Short Interest falls into.


LSTA
19GF Score
Lisata Therapeutics Inc LSTA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lisata Therapeutics Business Description

Other Exchanges 0HS8:UK8NE:Germany
Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
19GF Score

Get the complete analysis for LSTA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.45
Price